Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
On Oct. 10, 2024, the U.S. Centers for Disease Control and Prevention announced that a 2023 presumed outbreak…
On Aug. 5, 2024, North Carolina State University researchers revealed that an examination of the genetic material found…
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…
On May 31, 2024, the Bezos Center for Sustainable Protein launched at North Carolina State University. The Bezos…
On Jun. 6, 2023, President Biden announced the appointment of Dr. Mandy Cohen as Director of the Centers…
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
On Oct. 19, 2021, National Science Foundation funded scientists at the Yale School of Public Health and the…
On Jun. 1, 2021, Moderna announced that it had entered into an agreement with Thermo Fisher Scientific for…
On Jan. 5, 2021, AIM ImmunoTech announced that the active AMP-511 Expanded Access Program (EAP) had dosed its…
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a North Carolina-headquartered biopharmaceutical company specialized in…
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
On Jul. 26, 2016, Patheon announced the closing of its initial public offering of 34,226,191 of its ordinary…
On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…
On Oct. 7, 2015, the Nobel Prize in Chemistry for 2015 was awarded to Tomas Lindahl, Francis Crick…
On Oct. 1, 2015 the President and CEO of the Research Triangle Foundation (RTP), Bob Geolas, announced RTP’s…
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
On Sept. 30, 2014, David H. Murdock, owner and chair of Castle & Cooke, and builder and founder…
On Jun. 17, 2014, Grifols opened state-of-the-art North Fractionation Facility (NFF) in Clayton, NC, where production capacity of…
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…